businesses were offset by lower results from associates and joint ventures, largely due to shared loss from SGAH related to operational inefficiency which will be gradually improved. In Q1 2018, the Company
these transactions, the total size of all such acquisition and disposition transactions are lower than 15 per cent. Therefore, the Company is neither required to prepare and disclose the information
year 2019 To: Managing Director of the Stock Exchange of Thailand The Company would like to clarify the net profit for the 3rd quarter and 9-month periods of the year ending on 30th September 2019 had
projects and 8 project is pending so the SUTG company value decreases to 250.05 million baht by discounted cash flow method which is lower than offer to buy so that this offer is suitable and lower risk of
Osotspa Public Company Limited Q3’18 and 9M18 Management Discussion & Analysis 14 November 2018 Q3’18 and 9M18 Management Discussion & Analysis Page 1/7 Financial Highlights Q3’18 profit attributable
(MD&A) for the year 2019 Attention: The President The Stock Exchange of Thailand The Company wishes to present the Management Discussion & Analysis (MD&A) on the operating and financial status for the
lower of cost per unit of such product comparing with the same period of previous year. (3) Gross profit The Company and its subsidiaries’ gross profit was of Baht 61.43 million, increased by Baht 56.14
medical treatment in 2017 is a lower than 2016 about 2.38 %. 3. In the year 2017, Ramkhamhaeng Hospital Public Company Limited received share of profit from investment in associated company 192.35 million
administrative expenses / revenue of medical treatment in 2018 is a lower than 2017 about 6.90 %. 3. In the year 2018, Ramkhamhaeng Hospital Public Company Limited received share of profit from investment in
consolidated financial statements of Lee Feed Mill Public Company Limited and its subsidiaries for the second quarter ended June 30, 2019, of which the business operation results for the second quarter of 2019